title: MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro.
abstract: Recent investigations have highlighted that therapeutic artificial microRNAs could be promising candidates for cancer therapy through the modulation of tumor promoter or suppressor. MEK kinase 1 (MEKK1) is expressed by mitogen-activated kinase kinase kinase 1 (MAP3K1), an important kinase that links Ras activation to MAPK signaling. In the present study, we showed that synthetic MAP3K1-targeting artificial miRNA may provide considerable beneficial effects in the prevention of breast cancer growth and metastasis. We showed that MEKK1 was highly expressed in human breast cancer specimens, compared with adjacent normal tissues. Using a miRNA-expressing lentivirus system, we delivered a artificial miRNA (Map3k1 amiRNA) that targets MAP3K1 into 4T1 breast cancer cells and investigated the impact of MAP3K1-targeting miRNA on the growth and invasive behavior of breast cancer in vitro and in vivo. We found that overexpression of Map3k1 amiRNA led to impaired activities of p-ERK and p-p38. In addition, Map3k1 amiRNA induced marked proliferative impairment and invasive attenuation in breast cancer cells. However, Map3k1 amiRNA did not have evident influence on the apoptotic response of 4T1 cells. Moreover, using in vivo nude mice model, we identified that Map3k1 amiRNA attenuated tumor growth and lung metastasis of breast cancer cells. Taken together, our findings explicitly indicated that MEKK1 exerted important oncogenic property in breast cancer development, and MAP3K1-targeting artificial miRNA may provide promising therapeutic effects in the treatment of breast cancer.
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Chun
authors.initials: C
authors.lastname: Liu
authors.affiliation: Kangda College of Nanjing Medical University, 88 Chunhui Road, Lianyungang, Jiangsu People's Republic of China.
authors.forename: Shengjie
authors.initials: S
authors.lastname: Wang
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Shunxing
authors.initials: S
authors.lastname: Zhu
authors.affiliation: Kangda College of Nanjing Medical University, 88 Chunhui Road, Lianyungang, Jiangsu People's Republic of China.
authors.forename: Haifeng
authors.initials: H
authors.lastname: Wang
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Jiayi
authors.initials: J
authors.lastname: Gu
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Zeping
authors.initials: Z
authors.lastname: Gui
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Jin
authors.initials: J
authors.lastname: Jing
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Xiaofan
authors.initials: X
authors.lastname: Hou
authors.affiliation: Laboratory animal center of Nantong University, 19 Qixiu Road, Nantong, Jiangsu People's Republic of China.
authors.forename: Yixiang
authors.initials: Y
authors.lastname: Shao
keywords: Artificial miRNA; Breast cancer; MAP3K1; Metastasis; Tumor growth